Anais de Pesquisa Clínica e Laboratorial

• Página inicial do diário
• Arquivo
Autores
• Diretrizes para Autores
• Enviar manuscrito
Em detalhe
• Objetivo e escopo
• Ética de publicação
• Processo de revisão por pares
• direito autoral
• Contate-nos

Abstrato

The Therapeutic Targeting of the B cell acute lymphoblastic leukaemia

Daniele Manucci*

In on-going many years, the lead of uniform planned clinical preliminaries has prompted better reduction rates and endurance for patients with intense myeloid leukaemia and intense lymphoblastic leukaemia. Notwithstanding, high-risk patients keep on having substandard results, where chemo resistance and backslide are normal because of the endurance components used by leukaemia cells. One such component is through seizing of the bone marrow microenvironment, where solid haematopoietic hardware is changed or redesigned into a concealing ground or "safe-haven" where leukaemia cells can get away from chemotherapy-initiated cytotoxicity.